Study register · detail
Mixed
GRADE
Low
94 citations
Samplen = 1.756 Pat.
DurationAge range 16 to 18 years
ControlNo cannabis use
EndpointPsychotic experiences
Blindingn.a.
DesignProspektive Kohortenstudie
Key finding
The association between cannabis use and psychotic experiences was considerably attenuated by adjustment for tobacco use and other drug use and lost statistical significance.
Summary
ALSPAC cohort (n=1.756 adolescents, 16–18 years): Cannabis use at age 16 was associated with psychotic experiences at age 18 (OR=1,48, 95% CI 1,18–1,86); association attenuated after tobacco adjustment (OR=1,27, 95% CI 0,91–1,76); separability of cannabis and tobacco effects methodologically problematic since nearly all users used cannabis together with tobacco.
P
PopulationAdolescents aged 16–18 years from the ALSPAC cohort, n=1756
I
InterventionCannabis use and cigarette use at age 16 years
C
ControlNo cannabis use (reference group); additionally cigarette use as comparison condition
O
OutcomeCannabis use associated with psychotic experiences (OR 1,48; 95%-CI 1,18–1,86); after adjustment for cigarette smoking or other drug use attenuation to OR 1,27 (95%-CI 0,91–1,76) or 1,25 (95%-CI 0,91–1,73), no longer significant
Confidence in the evidence
Low
The second of four GRADE levels, the effect estimate is of limited reliability.
Quality profile
Sample size
★★★★★
Blinding
—
Effect size
Mixed
Citations / year
★★★★★
Authors
Share
Abstract
<h4>Background</h4>A clearer understanding of the basis for the association between cannabis use and psychotic experiences (PEs) is required. Our aim was to examine the extent to which associations between cannabis and cigarette use and PEs are due to confounding.<h4>Method</h4>A cohort study of 1756 adolescents with data on cannabis use, cigarette use and PEs.<h4>Results</h4>Cannabis use and cigarette use at age 16 were both associated, to a similar degree, with PEs at age 18 [odds ratio (OR) 1.48, 95% confidence interval (CI) 1.18-1.86 for cannabis and OR 1.61, 95% CI 1.31-1.98 for cigarettes]. Adjustment for cigarette smoking frequency (OR 1.27, 95% CI 0.91-1.76) or other illicit drug use (OR 1.25, 95% CI 0.91-1.73) substantially attenuated the relationship between cannabis and PEs. The attenuation was to a lesser degree when cannabis use was adjusted for in the cigarette PE association (OR 1.42, 95% CI 1.05-1.92). However, almost all of the participants used cannabis with tobacco, including those who classed themselves as non-cigarette smokers.<h4>Conclusions</h4>Teasing out the effects of cannabis from tobacco is highly complex and may not have been dealt with adequately in studies to date, including this one. Complementary methods are required to robustly examine the independent effects of cannabis, tobacco and other illicit drugs on PEs.
The impediment to action advances action.